December 02, 2018
Nordic Nanovector: Single administration Betalutin® is effective and well-tolerated in R/R iNHL patients: 6 month follow-up data presented at ASH
Media
December 02, 2018
Aprea Therapeutics Closes EUR 50 Million Financing
December 02, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego
December 01, 2018
Oncopeptides presents first interim data from the ongoing combination trial ANCHOR with melflufen at the 60th American Society of Hematology Meeting
November 30, 2018
US Court of Appeals denies Actavis’s petition for rehearing regarding validity of the Zubsolv® patent
November 30, 2018
Vicore Pharma’s Board of Directors has resolved on a directed share issue of around SEK 160 million to finance the continued development of the drug development programs VP01 and VP02
November 28, 2018
Targovax is invited to present at upcoming investor and industry conferences
November 27, 2018
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer
November 27, 2018
BioClin Therapeutics Announces Name Change to Rainier Therapeutics
November 22, 2018
Oncorena raises SEK 14.5 million to prepare for clinical study in advanced kidney cancer